A Highly Durable RNAi Therapeutic Inhibitor of PCSK9
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Koh, K.K. | - |
dc.date.available | 2020-02-27T20:42:22Z | - |
dc.date.created | 2020-02-12 | - |
dc.date.issued | 2017-05 | - |
dc.identifier.issn | 0028-4793 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/gachon/handle/2020.sw.gachon/6655 | - |
dc.description.abstract | [No abstract available] | - |
dc.language | 영어 | - |
dc.language.iso | en | - |
dc.publisher | Massachussetts Medical Society | - |
dc.relation.isPartOf | New England Journal of Medicine | - |
dc.title | A Highly Durable RNAi Therapeutic Inhibitor of PCSK9 | - |
dc.type | Article | - |
dc.type.rims | ART | - |
dc.description.journalClass | 1 | - |
dc.identifier.wosid | 000400442300027 | - |
dc.identifier.bibliographicCitation | New England Journal of Medicine, v.376, no.18, pp.e38 | - |
dc.description.isOpenAccess | N | - |
dc.identifier.scopusid | 2-s2.0-85019042609 | - |
dc.citation.startPage | e38 | - |
dc.citation.title | New England Journal of Medicine | - |
dc.citation.volume | 376 | - |
dc.citation.number | 18 | - |
dc.contributor.affiliatedAuthor | Koh, K.K. | - |
dc.type.docType | Letter | - |
dc.subject.keywordPlus | glucose | - |
dc.subject.keywordPlus | hydroxymethylglutaryl coenzyme A reductase inhibitor | - |
dc.subject.keywordPlus | inclisiran | - |
dc.subject.keywordPlus | low density lipoprotein cholesterol | - |
dc.subject.keywordPlus | monoclonal antibody | - |
dc.subject.keywordPlus | proprotein convertase 9 | - |
dc.subject.keywordPlus | low density lipoprotein cholesterol | - |
dc.subject.keywordPlus | low density lipoprotein receptor | - |
dc.subject.keywordPlus | serine proteinase | - |
dc.subject.keywordPlus | cardiovascular disease | - |
dc.subject.keywordPlus | cholesterol blood level | - |
dc.subject.keywordPlus | diabetes mellitus | - |
dc.subject.keywordPlus | drug mechanism | - |
dc.subject.keywordPlus | gene | - |
dc.subject.keywordPlus | genetic analysis | - |
dc.subject.keywordPlus | genetic variability | - |
dc.subject.keywordPlus | glucose intolerance | - |
dc.subject.keywordPlus | HMGCR gene | - |
dc.subject.keywordPlus | Letter | - |
dc.subject.keywordPlus | PCSK9 gene | - |
dc.subject.keywordPlus | priority journal | - |
dc.subject.keywordPlus | risk assessment | - |
dc.subject.keywordPlus | RNAi therapeutics | - |
dc.subject.keywordPlus | genetics | - |
dc.subject.keywordPlus | human | - |
dc.subject.keywordPlus | metabolism | - |
dc.subject.keywordPlus | RNA interference | - |
dc.subject.keywordPlus | Cholesterol, LDL | - |
dc.subject.keywordPlus | Humans | - |
dc.subject.keywordPlus | Proprotein Convertases | - |
dc.subject.keywordPlus | Receptors, LDL | - |
dc.subject.keywordPlus | RNA Interference | - |
dc.subject.keywordPlus | RNAi Therapeutics | - |
dc.subject.keywordPlus | Serine Endopeptidases | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
1342, Seongnam-daero, Sujeong-gu, Seongnam-si, Gyeonggi-do, Republic of Korea(13120)031-750-5114
COPYRIGHT 2020 Gachon University All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.